Pregled bibliografske jedinice broj: 549627
Efficacy and tolerability of multiple doses of Lu AA21004 in an 8-week treatment of adults with major depressive disorder.
Efficacy and tolerability of multiple doses of Lu AA21004 in an 8-week treatment of adults with major depressive disorder. // 2011 Annual Meeting of the American Psychiatric Association (APA)
Honolulu (HI), Sjedinjene Američke Države, 2011. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 549627 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Efficacy and tolerability of multiple doses of Lu AA21004 in an 8-week treatment of adults with major depressive disorder.
Autori
Henigsberg N ; Mahableshwarkar AR ; Jacobsen P ; Chen Y ; Thase ME
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
2011 Annual Meeting of the American Psychiatric Association (APA)
Mjesto i datum
Honolulu (HI), Sjedinjene Američke Države, 14.05.2011. - 18.05.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Lu AA21004
Sažetak
The results of this phase III, multicenter, randomized, double-blind, placebo-controlled clinical trial of Lu AA21004 in 560 adult patients with MDD, showed significant reduction in Hamilton Depression Rating Scale (HAM-D24) scores for all Lu AA21004 treatment groups (1 mg, 5 mg, 10 mg) compared with placebo after 8 weeks of treatment (p<0.0001). The most common treatment emergent adverse events (i.e., those reported by at least 10 percent of Lu AA21004 patients, and twice the rate of placebo) were nausea, headache and dizziness.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
